Merus Announces Third Quarter 2017 Financial Results and Clinical Highlights
Nov 30, 2017 12:00 pm UTC| Business
UTRECHT, The Netherlands, Nov. 30, 2017 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced financial results for...
Shipt Expands Delivery Pilot with Lidl
Nov 30, 2017 12:00 pm UTC| Business
SAN FRANCISCO, Nov. 30, 2017 -- Shipt, the fastest growing online grocery marketplace, today announced a pilot expansion with Lidl, one of the world’s largest retailers. This expansion follows a successful pilot launch...
Didier Boursier to Head Up Alliance Memory Regional Sales in France
Nov 30, 2017 12:00 pm UTC| Business
SAN CARLOS, Calif., Nov. 30, 2017 -- Alliance Memory today announced the appointment of Didier Boursier as the company’s first regional sales manager for France. Reporting to Sue Macedo, Alliance Memory’s EMEA managing...
Bearing Announces PEA to be Based on 20,000 Tonnes of Lithium Carbonate per Year
Nov 30, 2017 12:00 pm UTC| Business
VANCOUVER, British Columbia, Nov. 30, 2017 -- Bearing Lithium Corp. ("Bearing" or the "Company") (TSX Venture:BRZ) (OTCQB:BRGRF) (FRANKFURT:B6K1) is pleased to provide an update on the Maricunga lithium brine project in...
Provision Holding Announces Financial Results for the Quarter Ended September 30, 2017
Nov 30, 2017 12:00 pm UTC| Business
CHATSWORTH, Calif., Nov. 30, 2017 -- Provision Holding, Inc. (OTCQB:PVHO) today announced financial results for the quarter ended September 30, 2017. Business Highlights: Appointed retail industry veteran Mark...
Tonix Pharmaceuticals to Present at 10th Annual LD Micro Investor Conference
Nov 30, 2017 12:00 pm UTC| Business
NEW YORK, Nov. 30, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company in Phase 3 development of Tonmya®* (cyclobenzaprine HCI sublingual tablets), or TNX-102 SL, a U.S. Food and Drug...
Nov 30, 2017 12:00 pm UTC| Business
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Nov. 30, 2017 -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to...
FxWirePro- Major Economic Events for the day